| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/18/2007 | CN1947583A Face beauty care and health-care jellly, and its prepn. method |
| 04/18/2007 | CN1311081C Stem cell differentiation |
| 04/18/2007 | CN1310950C Telerance starch made of starch of de-amylopectin by iso-anylase |
| 04/18/2007 | CN1310948C Modified peptides as therapeutic agents |
| 04/18/2007 | CN1310945C Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/18/2007 | CN1310916C Hetero-bicyclic compounds |
| 04/18/2007 | CN1310915C Pyrido(2,1-a)isoquinoline derivatives as DPP-IV inhibitors |
| 04/18/2007 | CN1310912C 5-[4-[2(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salt |
| 04/18/2007 | CN1310891C N-piperidino-1-(2,4-dichlorophenyl)-4-methyl-5-(4-chlorophenyl)pyrazole-3-formamide organic salts and their pharmaceutical compositions |
| 04/18/2007 | CN1310885C Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 04/18/2007 | CN1310881C New 3-aryl-2-hydroxypropionic acid derivative I |
| 04/18/2007 | CN1310668C Medicine for treating diabetes, and its prepn. method |
| 04/18/2007 | CN1310643C Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205407 3-Substituted oxindole β3 agonists |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205321 preventing, treating diabetes mellitus, Syndrome X, cardiovascular disease , hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis in a mammal |
| 04/17/2007 | US7205309 Obesity therapy; administering orlistat |
| 04/17/2007 | US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 04/17/2007 | US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders |
| 04/17/2007 | US7205300 Aryl fused azapolycyclic compounds |
| 04/17/2007 | US7205297 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| 04/17/2007 | US7205290 Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use |
| 04/17/2007 | US7205286 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 04/17/2007 | US7205277 Zinc-free and low-zinc insulin preparations having improved stability |
| 04/17/2007 | US7205276 Zinc-free and low-zinc insulin preparations having improved stability |
| 04/17/2007 | US7205275 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | US7205134 Δ4-desaturase genes and uses thereof |
| 04/17/2007 | US7205127 Methods of treating insulin resistance with an inhibitor of an NAD(P)H oxidase |
| 04/17/2007 | CA2407759C Substituted phenylacetamides and their use as glucokinase activators |
| 04/17/2007 | CA2387915C Direct compression polymer tablet core |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2358885C Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them |
| 04/17/2007 | CA2348725C Vitamin d analogues |
| 04/17/2007 | CA2280960C Oxirancarboxylic acids for the treatment of diabetes |
| 04/17/2007 | CA2250586C Meta-substituted phenylene sulphonamide derivatives |
| 04/17/2007 | CA2196197C Retinoic acid x-receptor ligands |
| 04/12/2007 | WO2007041643A1 Dietary calcium for reducing the production of reactive oxygen species |
| 04/12/2007 | WO2007041641A1 Methods of reducing the production of reactive oxygen species and methods of screening or identifying compounds and compositions that reduce the production of reactive oxygen species |
| 04/12/2007 | WO2007041569A1 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
| 04/12/2007 | WO2007041368A2 Dpp iv inhibitor for use in the treatment of autoimmune diseases and graft rejection |
| 04/12/2007 | WO2007041076A2 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | WO2007041052A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 04/12/2007 | WO2007040440A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040439A1 New compounds ii |
| 04/12/2007 | WO2007040438A2 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 04/12/2007 | WO2007040436A1 Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040377A1 Antiobesity composition |
| 04/12/2007 | WO2007040244A1 Composition for relieving subjective symptoms of fatigue |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | WO2007040166A1 Novel fused pyrrole derivative |
| 04/12/2007 | WO2007040006A1 Activator for peroxisome proliferator-activated receptor (pparϝ) and composition containing the activator for preventing or ameliorating specific symptom |
| 04/12/2007 | WO2007040005A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPARα) AND COMPOSITION CONTAINING THE ACTIVATOR FOR PREVENTING OR AMELIORATING SPECIFIC SYMPTOM |
| 04/12/2007 | WO2007039945A1 Lipid metabolism improving composition |
| 04/12/2007 | WO2007039596A1 Nutritional formulation for promoting catch-up growth |
| 04/12/2007 | WO2007039482A1 Thiophene derivatives for the treatment of diabetes |
| 04/12/2007 | WO2007039297A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 04/12/2007 | WO2007039175A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039173A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039171A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007038943A1 Y2 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | WO2007024863A9 Methods and formulations for modulating lyn kinase activity and treating related disorders |
| 04/12/2007 | WO2007020213A3 Thiazolyl piperidine derivatives useful as h3 receptor modulators |
| 04/12/2007 | WO2007015002A3 Novel crystalline iv form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 04/12/2007 | WO2007012670A3 Compounds derived from 5-benzylidene imidazolidine 2,4-dione and their use as mchr-1 antagonists |
| 04/12/2007 | WO2007009720A3 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 04/12/2007 | WO2007009711A3 Octahydropentalene-substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/12/2007 | WO2007009701A3 Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome |
| 04/12/2007 | WO2007008937A8 Adiponectin variants |
| 04/12/2007 | WO2007006561A3 Improved crystalline form of the compound a-348441 |
| 04/12/2007 | WO2006045796A3 Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 04/12/2007 | US20070083050 Intermediate compound which is used for the preparation of pioglitazone |
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082947 Use of phthalide derivatives for the treatment and prevention of diabetes mellitus |
| 04/12/2007 | US20070082938 Polymorphs of bicifadine hydrochloride |
| 04/12/2007 | US20070082910 Specific nad(p)h oxidase inhibitor |
| 04/12/2007 | US20070082908 Bicycle pyrazole derivative |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082888 Containing a piperidine ring, e.g., N-(p-(1-(alpha(propyl-aminocarbonyl)benzyl)piperidin-4-yl)phen yl)-o-(p-CF3-phenyl)- benzamide, for therapy of hyperlipidemia, obesity and type II diabetes |
| 04/12/2007 | US20070082874 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/12/2007 | US20070082844 Regulation of food preference using GLP-1 agonists |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082077 Inhibitor of glucose absorption and method for producing the same |
| 04/12/2007 | US20070081980 Culture cells from pancreatic islets |
| 04/12/2007 | CA2624929A1 Antiobesity composition |
| 04/12/2007 | CA2624879A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 04/12/2007 | CA2624875A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 04/12/2007 | CA2624869A1 New compounds ii |
| 04/12/2007 | CA2624726A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624681A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624649A1 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 04/12/2007 | CA2624357A1 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624354A1 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624345A1 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624326A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |